Medical Training
Resume:
Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD
Consultant Medical Oncology
***********@*******.***
Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD
Consultant Clinical Oncology
**** ***** ****, ****** **rks, NS, Canada
***********@*******.***
Degrees
Cairo University – Kasr Al Aini Medical School, Cairo University
Medical Doctorate Degree MD (PhD equivalent)
in Radiotherapy( Medical Oncology& Radiation Oncology ) Nov 2004
Master Degree MSc in Radiotherapy Nov 1984
Bachelor in Medicine & Surgery MB,BCh Dec 1978
Clinical Experience
Saudi Arabia Ministry of Health from Aug 2006 – to Oct 2013
Oct 2011 – Oct 2013
Associate Consultant Medical Oncology -Jeddah Oncology Center -King Abdul Allah Medical City
Oct 2009 – Sept 2011
Associate Consultant Medical Oncology - Oncology Center - King Abdul Aziz Hospital
Aug 2006 – Sept 2009
Specialist Medical Oncology - Oncology Center - King Abdul Aziz Hospital
Egypt April 1980 - July 2006
Worked at EAEA Egypt Atomic Energy Authority
April 2005 – July 2006
Lecturer Radiotherapy
March 1998 -March 2005
Assistant Lecturer Radiotherapy
Nov 1984 – Nov 1985
Specialist Radiotherapy
April 1980 – Oct 1984
Registrar
March 1979 –March 1980
House officer in Cairo University Hospitals (2000 beds)
Nov 1981- Nov 1983
Resident in Clinical Oncology Department Cairo University Teaching Hospital
KSA Dec 1985 – Nov 1997
Specialist Radiation Oncology – Dr. Ghassan N Pharaon Hospital
1
Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD
Consultant Medical Oncology
***********@*******.***
Duties
• Examination of cancer patients, either as new referral or follow up patients
• Ordering the necessary investigations for staging workup and routine follow up
• Prescribing non-surgical treatment in the form of chemotherapy, hormonal or biological therapy for
inpatients and outpatients
• Participating in multidisciplinary clinics
• Clinical rounds for the inpatients
• Consultation for referral from other consultants in different specialties.
• Sharing in the rotation for consultants on call
• Designing and sharing in research work
• Sharing in the training program of residents in Oncology Center
• Vice president of scientific committee for Continuous Medical Education in Oncology Center
Research Experience:
Member of Gulf Oncology Research Group (GORG) since May 2008
Contributed as co-invetigator in:
GORG 001 Study “A multicenter Prospective Phase II Trial of Neo-adjuvant (FEC 100) Cisplatin
Docetaxel + Trastuzumab in women who overexpressed or amplified Her2/neu with locally advanced
Breast Cancer” 2010
GORG 002 Study “Randomized Phase III study to determine the effectiveness of Vitamin D2
(Ergocalciferol) given with Docetaxel versus Docetaxel in Patients with Metastatic Breast Cancer”
2011
Study ML18147 “A randomized, open-label phase III Intergroup study: Effect of adding bevacizumab
to cross over fluoropyrimidine-based chemotherapy (CTx) in patients with metastatic colorectal cancer
and disease progression under first-line standard CTx / bevacizumab combination”. July2009-2011
Also shared as coauthor in the study “Lapatinib-based therapy for women with advanced/metastatic
HER2+ breast cancer”.,ASCO 2014, abstract.
Author of -“Assessment of Clinical and Pathological Response of Locally Advanced Breast Cancer to
Upfront Triplet Combination Chemotherapy” (Docetaxel, Epirubicin and Cyclophosphamide),
Cairo Univ.J. Sept., 2008 (abstract form in BMJ (Middle East)
PhD Thesis -"A Study of the Relationship between Biological Markers and Radioresistance and
Chemoresistance in Squamous Cell Carcinoma of Head and Neck" an M.D. Thesis, Cairo Univ.,
2001
M.S.Thesis "Clinicoepidemiological Study of Oropharyngeal Carcinoma" A M.Sc. Thesis, Cairo
University,
1982.
I have experience in designing clinical trials protocols and CRF as well as scientific writing,
Licenses
Valid license as consultant oncologist in KSA till Apr 2016
License of Egyptian Syndicate for Physicians.
2
Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD
Consultant Medical Oncology
***********@*******.***
Applied for defined license in NS, Canada
Member of
General Syndicate for Physician in Egypt since 1980
Egypt Cancer Society
Saudi Cancer Society
Training Courses & Workshops
* Abdominal Ultrasonography for physicians
Obstetrics and Gynecology Ultrasonography for Physicians
Cairo University Hospitals - Nov 1986
*Multidisciplinary Course in Mammography
North West National Training Centre UK - Mar 1996
*Practical Training clinical attachment
North West National Training Centre, Manchester UK - Mar 1995
*Fellow of Baltimore University Hospital, MD USA - Sep 1997
*Application of Immunohistochemistry
Eye Research Centre, Cairo - Sep 1998
*Medical Treatment of Radiation Accidents"
Arab Atomic Energy Authority, Cairo - Nov 1999
*Cell Culture & Bioreactor Technology
Egyptian Atomic Energy Authority, Cairo – Oct 2001
*NIH Clinical Research Training Online Course 2011
Conferences Symposia & Workshops
ECCO ESMO Amsterdam Sep 2013
June 2012 ASCO in Chicago, IL USA
March 2012 Women Cancer Conference in Austin, TX USA
Dec 2011 Breast Cancer Conference in San Antonio, TX USA
Nov 2010 Annual Conference of British National Cancer Research Institute in Liverpool, UK
Nov 2009 Annual Conference of British National Cancer Research Institute in Birmingham, UK
{Poster presentation}
March 2009 Breast Cancer Conference in St.Gallen, Switzerland
3
Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD
Consultant Medical Oncology
***********@*******.***
Publications&Clinical Trials
1- "Clinicoepidemiological Study of Oropharyngeal Carcinoma" A M.Sc. Thesis, Cairo University,
1982.
2-"Role of Adjuvant Systemic Therapy in the Management of Breast Cancer", J.Egypt Nat.Can.Inst.
Vol.5, No3:605, 1992
3-"A Study of the Relationship between Biological Markers and Radioresistance and
Chemoresistance in Squamous Cell Carcinoma of Head and Neck" an M.D. Thesis, Cairo Univ.,
2001
4-“Assessment of Clinical and Pathological Response of Locally Advanced Breast Cancer to Upfront
Triplet Combination Chemotherapy” (Docetaxel, Epirubicin and Cyclophosphamide),
Cairo Univ.J. Sept., 2008 (abstract form in BMJ (Middle East)
5-Case Report: “Premenopausal Patient with HER2+ Metastatic Breast Cancer Treated with Lapatinib
And Capcitabine” The Oncologist Aug 2010, 68
6- “Lapatinib-based therapy for women with advanced/metastatic HER2+ breast cancer”.,ASCO 2014, abstract.
7- Co-investigator in A multicenter prospective Phase II trial of neo-adjuvant (FEC 100)/Cisplatin- Docetaxel with or
without Trastuzumab in locally advanced breast cancer. Gulf Oncology Research Group (GORG-001).
7- Co-investigator in A randomized, open-label phase III Intergroup study: Effect of adding bevacizumab to cross
over fluoropyrimidine-based chemotherapy (CTx) in patients with metastatic colorectal cancer and disease
progression under first-linestandard CTx / bevacizumab combination. July 2010
8-Co-investigator in Vit D3 study Randomized phase III trial to determine the effectiveness of Vitamin D2
(Ergocalciferol) given with Docetaxel versus Docetaxel in patients with metastatic breast cancer.
References:
Available upon request
4
Contact this candidate